Viomycin and capreomycin belong to the tuberactinomycin family of antibiotics, which are among the most effective antibiotics against multidrug-resistant tuberculosis. Here we present two crystal structures of the 70s ribosome in complex with three tRNAs and bound to either viomycin or capreomycin at 3.3- and 3.5-Å resolution, respectively. Both antibiotics bind to the same site on the ribosome, which lies at the interface between helix 44 of the small ribosomal subunit and helix 69 of the large ribosomal subunit. the structures of these complexes suggest that the tuberactinomycins inhibit translocation by stabilizing the tRNA in the A site in the pretranslocation state. In addition, these structures show that the tuberactinomycins bind adjacent to the binding sites for the paromomycin and hygromycin B antibiotics, which may enable the development of new derivatives of tuberactinomycins that are effective against drug-resistant strains.
a r t i c l e s
Despite modern multidrug therapy 1 and ongoing drug development 2, 3 , tuberculosis continues to be a major health concern, with 9 million new cases and 2 million deaths worldwide in 2007 alone 4 . Thus, the emergence of strains of Mycobacterium tuberculosis, the causative agent of tuberculosis, that are resistant to the most widely used antibiotics is a significant health problem. Among the most effective antibiotics against multidrug-resistant tuberculosis are the tuberactinomycins, which inhibit protein synthesis by interacting with both ribosomal subunits in a manner that was previously unknown 5 .
The tuberactinomycin family of antibiotics consists of several closely related compounds containing the same pentapeptide core composed of l-serine and the nonproteinogenic residues 2,3-diaminopropionate, l-capreomycidine and β-ureidodehydroalanine (Fig. 1) . The members of the tuberactinomycin family differ in their residue side chain modifications, including the amino acylation with β-lysine 6 . Although viomycin was the first member of this family to be identified, only capreomycin is commonly used clinically as a second-line antibiotic against infections by Mycobacterium tuberculosis 7 . Capreomycin is a mixture of four isoforms, all of which are active in vitro against mycobacteria 8 . To simplify the discussion here, only the IA isoform of capreomycin is considered (Fig. 1) ; the other isoforms are not modified with β-lysine and/or have the serine of the cyclic pentapeptide core reduced to alanine (Supplementary Fig. 1 ).
In addition to its important role in the treatment of tuberculosis, viomycin has been pivotal in biochemical studies of protein synthesis. Viomycin interacts with both the large and the small ribosomal subunits 5 and prevents the translocation of the ribosome along the mRNA 9 . During translocation, a deacylated tRNA moves from the P site to the E site and the peptidyl-tRNA moves from the A site to the P site, vacating the A site for the next aminoacylated tRNA. Elongation factor G (EF-G) facilitates translocation through GTP hydrolysis. Although viomycin allows the binding of EF-G as well as GTP hydrolysis, it completely inhibits translocation 9 . To confirm the proposed binding site and illuminate the mechanism of translocational inhibition, we set out to determine the structures of both capreomycin and viomycin bound to the ribosome.
Results

structure determination
We determined the cocrystal structure of the 70S ribosome from Thermus thermophilus in complex with either viomycin or capreomycin, as well as three full-length tRNAs and a short piece of mRNA, at 3.3-and 3.5-Å resolution, respectively. Both antibiotics were bound to T. thermophilus 70S ribosomes that had been complexed with mRNA and tRNA before crystallization. The preparation of ribosomes containing the three bound tRNAs required the incubation with the ternary complex of EF-Tu, the nonhydrolyzable GTP analog GMP-PNP and Gln-tRNA Gln (see Online Methods). We calculated unbiased difference Fourier maps using the observed amplitudes from crystals of the complex and the amplitudes and phases that were calculated from a model of the 70S ribosome without the bound ligands obtained by molecular replacement. We manually fit each antibiotic as well as the tRNA and mRNA into the difference electron density map (Fig. 1c) , and we then refined the coordinates of the entire ribosome complex with the antibiotic, tRNAs and mRNA. The distinctive axial conformation of the six-membered ring of the l-capreomycidine side chain allowed the central tuberactinomycin ring to be unambiguously placed into the difference Fourier maps despite the presence of the four isoforms of capreomycin.
a r t i c l e s
Classical state of tRNAs
The three tRNA molecules are bound in the classical A, P and E sites in this complex with the 70S ribosome. The anticodons of both the A-and P-site tRNAs form base pairs with the corresponding codons of the mRNA. As observed 10 , the bases A1492 and A1493 make stabilizing A-minor interactions with the two base pairs between the codon and anticodon of the A-site tRNA and mRNA. The structure of the peptidyl transferase center and the bound CCA ends of both the A-site and P-site tRNAs is identical to that of the Haloarcula marismortui large subunit complexed with A-and P-site substrate analogs 11 , consistent with the results of recent work 12 (Supplementary Fig. 2 ).
Binding site of tuberactinomycins
Both viomycin and capreomycin bind to a site that lies between the large and small subunits in a cleft formed between helix 44 of the 16S rRNA (h44) and the tip of helix 69 of 23S rRNA (H69) (Fig. 2) . The macrocycle of both drugs lies within hydrogen bonding distance of the ribose phosphate backbone of the binding pocket, which is formed by residues A1913 and C1914 of the 23S rRNA and residues A1493 and G1494 of the 16S rRNA. This explains why cleavage of the phosphate backbone between A1493 and G1494, as produced by colicin E3, renders the ribosome less sensitive to inhibition by viomycin 13 . The orientation of the macrocycle is also determined by its stacking onto G1491 and G1494, which places the six-membered ring of the capreomycidine side chain in the vicinity of A1492 and A1493 of the 16S rRNA. The guanidinium moiety in the six-membered ring of capreomycidine effectively positions the antibiotic via a salt bridge to the phosphate of A1493 of the 16S rRNA (Fig. 2c) .
Previous biochemical work 14 has established the importance of the capreomycidine side chain of the tuberactinomycin ring for tuberactinomycin's inhibition of ribosome activity, suggesting that its steric restriction of the orientation of A1492 and A1493 contributes to the inhibitory effect of viomycin and capreomycin; in the presence of these antibiotics, A1492 and A1493 cannot move to the positions they occupy in the apo ribosome.
The main difference between the binding of viomycin and capreomycin to the 70S ribosome is in the β-lysine side chain of each drug. Because only two of the four isoforms of capreomycin possess the β-lysine modification, the electron density observed for β-lysine in the complex between capreomycin and the ribosome is weak. The β-lysine side chain in the capreomycin complex extends from the macrocycle past A1913 of the 23S rRNA and toward the A-site tRNA, whereas in the viomycin complex it extends past G1491 of the 16S rRNA toward the mRNA. Neither position of the β-lysine modification is essential for the activity of the antibiotic 15, 16 , an observation that is confirmed by the lack of extensive hydrogen bonding between the ribosome and the modification.
DIsCussION
Resistance mutations
The structures of both viomycin and capreomycin bound to the ribosome confirm a wealth of previous biochemical and genetic studies suggesting that the tuberactinomycins bind at the interface between the small and large ribosomal subunits. Both tuberactinomycins bind to the well-conserved intersubunit bridge B2a formed by the interactions of helix H69 of the 23S rRNA and helix h44 of the 16S rRNA. Mutations of nucleotides surrounding the antibiotic binding site in both H69 and h44 confer resistance to capreomycin and viomycin 17 . The loss of 2′-methylation of C1409 of h44 and C1920 of H69 reduces the susceptibility of M. tuberculosis to capreomycin and viomycin inhibition by two-to eightfold 7 but has no effect on capreomycin a r t i c l e s sensitivity in T. thermophilus 17 . Of particular interest is the mutation A1913U, which was identified in T. thermophilus 17 . In the structure of the apo 70S ribosome, A1913 is swung out of the loop at the base of H69 and is inserted into h44 (ref. 18 ), a position that partially overlaps with the binding site of both capreomycin and viomycin. The mutation of A1913 to uridine may confer resistance to these antibiotics because this potential clash between A1913 and the antibiotic could be alleviated, which also suggests that bound tuberactinomycins inhibit translocation by preventing A1913 from moving into the position it occupies in the structure of the apo 70S ribosome.
The bridge between the subunits formed by H69 and h44 not only is essential for the association of ribosomal subunits in the absence of tRNA 19 but also contacts the A-site tRNA, implying that it has roles in several ribosomal functions, such as initiation, decoding or ribosome recycling [20] [21] [22] . Several different orientations of this bridge have been observed in the crystal structures of ribosome complexes with tRNAs, release factors and antibiotics 18, [22] [23] [24] [25] [26] [27] [28] . The positions of A1913 of the 23S rRNA and A1492 and A1493 of the 16S rRNA are critical in the decoding of the mRNA. The positions of A1492, A1493 and A1913 in the structures presented here are identical to those observed in complexes containing mRNA and cognate tRNA in the A site 10, 24 . During the binding of the cognate A-site tRNA, A1492 and A1493 swing out of h44, and along with G530 of the 16S rRNA they form A-minor interactions with the helix that is created by the codonanticodon interactions between the cognate tRNA and the mRNA 10 . In addition, A1913 rotates toward the A-site tRNA to hydrogen bond with the 2′-OH of nucleotide 37 of the A-site tRNA 24 .
the state of tRNAs
Chemical modification experiments 29 and cryo-electron microscopy structures 30 show that the tRNAs can assume a hybrid state, in which the tRNAs bound in the A site and P site adopt the A/P and P/E hybrid states, respectively, after the peptidyl transfer reaction. There are reports on the effects of viomycin on these hybrid states, but these are not in agreement with each other. These disagreements might just be the consequence of the differing ionic conditions used in these experiments, which could influence the sensitive equilibrium between the two states 30, 31 . Single-molecule fluorescence resonance energy transfer experiments suggest that viomycin not only stabilizes the tRNA in the classical state but also suppresses the rate of sampling the hybrid state by the tRNAs after peptidebond formation 31 . Other kinetic data suggest that the binding of viomycin to the 70S ribosome after the addition of EF-G and GTP blocks the movement of the A-site tRNA but not the formation of the hybrid state by the P-site tRNA 32 . Chemical modification experiments seem to indicate that viomycin traps the tRNAs in the A/P and P/E hybrid state 33 . Single-molecule fluorescence resonance energy transfer experiments 34 have correlated both the tRNA hybrid state and the viomycin-stalled state with the ratcheted state of the ribosome, in which the large subunit is rotated relative to the small subunit and tRNAs. We cannot confirm or refute the possibility that these antibiotics bind to the 70S ribosome in the hybrid state, but our results show that they can bind to the classical state.
In both structures of the ribosome in complex with viomycin and capreomycin, the ribosome is observed in the nonratcheted state, with the bound tRNAs in the classical A, P and E sites, rather than in the ratcheted state with the bound tRNAs in the hybrid state. Crystal packing and/or the presence of an E-site tRNA in these crystals may prevent the formation of the hybrid state. These structures show that viomycin is able to bind to the ribosome when the A-site tRNA is in the classical state, but we cannot exclude the possibility that viomycin a r t i c l e s is capable of binding to the ratcheted state as well. Cryo-electron microscopy structures have revealed that bridge B2a, which consists of h44 and H69, remains intact after spontaneous ratcheting of the subunits; however, slight movements of h44 and H69 have been observed 30 . This is further supported by recent crystal structures of the 70S ribosome from E. coli captured in intermediate states of ratcheting, showing that the contacts in B2a persist in the different proposed intermediate states 35 . Whether the binding of viomycin inhibits the movement of B2a associated with ratcheting is unknown.
Mechanism of inhibition by tuberactinomycins
The many different classes of antibiotics that affect translocation of the tRNAs on the ribosome, such as the tuberactinomycins or aminoglycosides (reviewed in ref. 36) , either stabilize the tRNA in the pretranslocation state or interfere with the conformational changes of the ribosome or tRNA required for translocation 37 . Paromomycin is an aminoglycoside that binds in the major groove of h44 and stabilizes A1492 and A1493 of the 16S rRNA in the 'flipped-out' position that the bases adopt during the readout interaction between the tRNA anticodon and the mRNA 10 . Because paromomycin stabilizes the binding of both cognate and near-cognate tRNAs to the A site, it not only inhibits translocation but also promotes miscoding 38 . Notably, although hygromycin B also binds to h44, it causes only A1493 to adopt a unique orientation, in which the base interferes with the movement of the tRNA from the A site to the P site 39 . Viomycin and capreomycin affect the positioning of A1492 and A1493 (Fig. 3) and also appear to affect the position of A1913 of the 23S rRNA. A1913 adopts a position where it forms hydrogen bonds with the A-site tRNA. Consistent with our results, biochemical evidence reveals that viomycin increases the affinity of tRNA to the A site by 1,000-fold 37 and promotes the back translocation of the complex of tRNA with mRNA on the ribosome 40 . Therefore, we propose that the tuberactinomycins inhibit translocation, stabilizing the tRNA in the A site.
We suggest that these two structures of tuberactinomycins in complex with the 70S ribosome will enable the creation of new anti-tuberculosis antibiotics. The tuberactinomycins have several functional groups that can be modified without decreasing the potency of their translational inhibition, making them particularly amenable for structurally based drug design 16 . Furthermore, the adjacent location of the tuberactinomycin binding site with those of paromomycin and hygromycin should provide a starting point for the design of novel derivatives of tuberactinomycins that are chemically linked to modified portions of the other antibiotics. These new compounds could be effective against drug-resistant strains of tuberculosis, including those with mutant efflux pumps.
MetHODs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Accession codes. Protein Data Bank: Atomic coordinates for both 70S ribosomes in the asymmetric unit of both complexes have been deposited with accession numbers 3KNH, 3KNI, 3KNJ and 3KNK for the viomycin-bound 70S ribosome structure and 3KNL, 3KNM, 3KNN and 3KNO for the capreomycin-bound 70S ribosome structure. 
ONlINe MetHODs
Purification of 70S ribosomes, mRNA, tRNA and ternary complex. We prepared Thermus thermophilus 70S ribosomes and fMet-tRNA as described previously 24, 41, 42 . The mRNA was chemically synthesized by Integrated DNA Technologies and contained a codon for glutamine following the fMet start codon. We formed the ternary complex of EF-Tu, Gln-tRNA Gln and GMP-PNP from purified components. The plasmids for the overexpression of His-tagged T. thermophilus EF-Tu and His-tagged T. thermophilus EF-Ts were provided by P. Nissen and M. Sprinzl, respectively. We expressed both EF-Tu and EF-Ts and purified them via nickel nitrilotriacetic acid column followed by gel filtration. We prepared tRNA Gln and glutaminyl-tRNA synthetase as described previously 43 . Before ternary complex formation with Gln-tRNA Gln , we exchanged the nucleotide bound to EF-Tu to GMP-PNP. We purified the final ternary complex with a reverse ammonium sulfate gradient on a phenyl resource column (GE).
Formation of the 70S ribosome complex. We formed the complex of 70S ribosomes with viomycin (or capreomycin), mRNA and three tRNAs in 5 mM HEPES-KOH (pH 7.6), 10 mM MgCl 2 , 50 mM KCl and 10 mM NH 4 Cl at 55 °C. We programmed 4 µM of 70S ribosomes with 8 µM mRNA for 15 min before incubating the ribosomes with 8 µM fMet-tRNA i
Met for an additional 30 min. We added 16 µM ternary complex to the reaction mixture and incubated it for 30 min, then added either 100 µM viomycin or 250 µM capreomycin and performed a final incubation of 30 min. We cooled the complex to room temperature (25 °C) and centrifuged it for 1 min at 16,000g before setting up the crystallization experiment. 
Data collection.
We collected X-ray diffraction data at beamline X29 at Brookhaven National Laboratory and beamline 24ID at the Advanced Photon Source. We collected complete datasets for both the viomycin and capreomycin crystals from four separate regions of the same crystal. We integrated and scaled the raw data with the XDS package 44 . The crystals belong to the orthorhombic space group P2 1 2 1 2 1 with two copies of the ribosomal complex in the asymmetric unit.
Structure determination. We solved each structure by molecular replacement, using the small and large ribosomal subunits from the structure of the T. thermophilus 70S ribosome bound to mRNA and tRNA 24 (PDB 2J00 and 2J01, respectively), with Phaser in the CCP4 programming suite 45 . We included neither the tRNAs nor the mRNA ligands in the search models. We refined the initial molecular-replacement structures by rigid-body refinement, with the ribosome split into multiple domains, using REFMAC in the CCP4 programming suite 46 . After rigid-body refinement in REFMAC5, we further refined each structure using Phenix, which enabled us to calculate difference electron density maps using F o -F c coefficients 47 . Clear difference electron densities were visible for the three full-length tRNAs, the mRNA and both antibiotics, which were used to build the ligands.
Structure building. We carried out iterative rounds of model building and refinement in Coot 48 and CNS 49, 50 . The crystal structure of viomycin has been reported 51 , but the coordinates are not available in the Cambridge Structural Database. The initial coordinates of viomycin and capreomycin were based on the combination of a model derived from the published crystal structure of tuberactinomycin 52 and chemical structure information and energy minimization with the program Desmond 53 . We energy-minimized the initial structures using OPLS-AA force field 54 and TIP4P water model 55 via steepest descent/limited memory Broyden-Fletcher-Goldfarb-Shanno update (L-BFGS), followed by 1.2 ps of five-stage simulated annealing (0, 300 K, 600 K, 900 K, 300 K) and another cycle of energy minimization. We took the starting coordinates for the tRNA and mRNA ligands from PDB ID 2WGK 12 . We built the deacylated noncognate tRNA bound in the E site with the same sequence as the A-site tRNA Gln . The statistics on the X-ray data and the refinement are available in Table 1 . We generated the figures with PYMOL 56 .
